RLYB
Rallybio Corp
NASDAQ: RLYB · HEALTHCARE · BIOTECHNOLOGY
$8.98
+1.13% today
Updated 2026-04-30
Market cap
$46.55M
P/E ratio
—
P/S ratio
54.25x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$2 – $11
Volume
0.2M
Rallybio Corp (RLYB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.03M | $-22.04M | $-45.53M | $-57.28M | $-60.27M | $-49.28M | $-29.81M |
| Capital expenditures | $188000.00 | $137000.00 | $333000.00 | $54000.00 | $12000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $194000.00 | $704000.00 | $3.65M | $9.50M | $10.92M | $7.99M | $5.31M |
| Free cash flow | $-15.21M | $-22.18M | $-45.87M | $-57.34M | $-60.28M | $-49.28M | $-29.81M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $35.10M | $-118.38M | — | — | — |